Latest updates for Enbrel

Fresh curated links around Enbrel are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Vunakizumab bests placebo in radiographic axial spondyloarthritis
  • This drug delayed rheumatoid arthritis for years after treatment ended
  • FDA OKs Immgolis as first golimumab biosimilar for UC, RA

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

healio.com /1 month ago

Vunakizumab bests placebo in radiographic axial spondyloarthritis

Vunakizumab, a novel interleukin 17a monoclonal antibody, is superior to placebo in radiographic axial spondyloarthritis symptom improvement, according to data published in JAMA Ne...

Read source
sciencedaily.com /1 month ago

This drug delayed rheumatoid arthritis for years after treatment ended

A promising new study suggests rheumatoid arthritis may not be as inevitable as once thought for people at high risk. Researchers found that just one year of treatment with the imm...

Read source
healio.com /1 month ago

FDA OKs Immgolis as first golimumab biosimilar for UC, RA

The FDA has approved golimumab-sldi as the first interchangeable biosimilar to Simponi for ulcerative colitis.Golimumab-sldi (Immgolis, Accord BioPharma) has been approved as a bio...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Enbrel

healio.com

Recent coverage from public sources
Public source

healio.com

Recent coverage from public sources
Public source

sciencedaily.com

Recent coverage from public sources
Public source